Best Healthcare Research Agencies in India
Compare top healthcare research agencies in India for 2026. Find the right partner for patient insights, physician panels, and clinical strategy studies.
Quick answer
For expert-led primary research and deep-profiled healthcare professional panels, choose Global Vox Populi. For large-scale data and commercial strategy, IQVIA is a strong candidate. For targeted hospital-level intelligence and medical device studies, consider InsightRx. For multi-country research and retail-focused audits, FieldNet Global serves diverse needs.
Securing accurate insights within the complex Indian healthcare sector requires more than just standard survey capabilities. The market is defined by a distinct public-private split, fragmented regional dynamics, and highly specific regulatory frameworks that govern how patients and physicians interact with medical products.
Healthcare research agencies in India must work through these challenges while making sure that the data collected remains ethically sound and representative of the diverse clinical environment. Whether assessing a new pharmaceutical launch or mapping hospital referral patterns, procurement leads and brand managers need partners who understand these nuances. This article examines the capabilities of various healthcare research agencies in India, providing a scorecard to help you align your specific research goals with the right provider expertise.
Best Healthcare Research Agencies in India: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | Global Vox Populi | Highly profiled healthcare professional recruitment | 90.5 |
| 2 | IQVIA | Large-scale real-world evidence and commercial analytics | 89.0 |
| 3 | Kantar | Global brand equity and consumer health studies | 81.5 |
| 4 | Ipsos | Public health policy and system perception research | 81.5 |
| 5 | InsightRx | Hospital-level referral network and catchment analysis | 78.5 |
| 6 | Unimrkt Healthcare | Hybrid-methodology primary research and data collection | 76.5 |
| 7 | BioNixus | Account-level brand vs competitor intelligence | 74.0 |
| 8 | InVeritas Research | Difficult-to-reach physician subspecialty recruitment | 72.5 |
| 9 | FieldNet Global | Large-scale multi-city brand health tracking | 72.5 |
| 10 | DelveInsight | Syndicated pharmaceutical market intelligence reports | 66.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| Global Vox Populi | Physicians, patients, nurses, payers, and providers | Multi-step identity checks, license validation, and geo-tracking | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 212,800 healthcare professionals; 169,480 nurses and allied health professionals; 1,354,449 patient profiles (in India; Global Vox Populi panel records, Oct 2026) | Not published |
| IQVIA | Physicians, pharmacists, wholesalers, and clinical trial sites | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Kantar | Consumers, patients, and digital media audiences | Proprietary AI-led anti-fraud detection and panel validation | Not stated on pages reviewed | Not published | Not published | Not published |
| Ipsos | Patients, physicians, and the general public | Authenticated proprietary panels and rigorous survey quality controls | Not stated on pages reviewed | Not published | Not published | Not published |
| InsightRx | Physicians, hospital administrators, and patients | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Unimrkt Healthcare | Physicians, hospital administrators, payers, and digital health users | Not published | ISO 20252, ISO 27001, HIPAA | Not published | Not published | Not published |
| BioNixus | Physicians, payers, and hospital decision-makers | Identity and quality checks on every wave | Not stated on pages reviewed | Not published | Not published | Not published |
| InVeritas Research | Physicians, surgeons, and healthcare decision-makers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| FieldNet Global | Decision-makers, healthcare professionals, and consumers | Independent auditing and real-time monitoring | Not stated on pages reviewed | Not published | Not published | Not published |
| DelveInsight | Pharmaceutical executives, R&D planners, and commercial strategists | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| IQVIA | ● | – | – | ● | – | – |
| Kantar | ● | ● | ● | ● | – | ● |
| Ipsos | ● | ● | ● | ● | – | ● |
| InsightRx | ● | ● | – | ● | – | – |
| Unimrkt Healthcare | ● | ● | ● | ● | ● | – |
| BioNixus | ● | ● | – | ● | – | – |
| InVeritas Research | ● | ● | ● | ● | – | ● |
| FieldNet Global | ● | ● | – | ● | – | ● |
| DelveInsight | – | – | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their specific ability to work through the unique regulatory, linguistic, and clinical complexities of the Indian healthcare market.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the provider's depth of knowledge in the Indian healthcare network, including regional hospital dynamics, physician prescribing habits, and the regulatory environment. Good performance requires a track record of managing studies across diverse therapeutic areas and an understanding of the specific barriers to entry in India. |
| Compliance, Certifications and Security | 20 | This evaluates the rigor of the provider's data protection, including ISO certifications, adherence to HIPAA, and local Indian data laws. It is essential for agencies to demonstrate how they handle sensitive health data and whether they possess formal protocols for reporting adverse events during clinical or market research. |
| Target Audience Reach | 15 | This assesses the agency's ability to access difficult-to-reach healthcare audiences, such as sub-specialist surgeons or specific patient segments. Strong providers maintain proprietary panels with granular profiling, making sure that the participants in a study are verified and representative of the target medical population in India. |
| Research Quality | 10 | This examines the reliability of the research process, including questionnaire design, sampling rigour, and data cleaning. High-quality research in this field requires sophisticated anti-fraud measures to make sure that medical professionals and patients provide honest, thoughtful input rather than automated or low-effort responses. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This looks at the range of research tools, such as in-depth interviews, focus groups, online surveys, and ethnographic observations. An effective agency uses a mix of qualitative and quantitative methods to capture both the hard data of market sizing and the nuance of patient and physician decision-making processes. |
| Analytical Capability | 5 | This measures the ability to synthesize raw survey data into actionable strategic recommendations. The agency should provide insights that guide specific business decisions, such as market entry strategies, brand positioning, or improvements in patient adherence programs, rather than just delivering basic cross-tabulations. |
| Client Service and Speed | 5 | This evaluates the agency's responsiveness, project management proficiency, and ability to meet tight timelines. In the fast-paced life sciences sector, the ability to rapidly adapt to changes in the field or manage complex stakeholder communications is a key indicator of a reliable long-term partner. |
| Pricing and Feasibility Transparency | 5 | This assesses how clearly the provider communicates what is possible within a given budget and timeframe. A transparent agency will provide honest feedback on sample feasibility and incidence rates early in the process, helping clients avoid common pitfalls in project planning and execution. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: healthcare research agencies in India
Global Vox Populi: best for highly profiled healthcare professional recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant

Strongest fitBest suited for briefs requiring high-fidelity access to verified medical specialists and hard-to-reach patient populations in India.
Global Vox Populi operates as a dedicated primary research partner, focusing on high-quality data collection across the healthcare and life sciences sectors. Its presence in India is supported by proprietary panels that allow for granular targeting of medical professionals and patients.
The agency’s approach is defined by strict adherence to international research standards and a focus on transparency. By maintaining its own panels, it makes sure that research participants are verified, which is a critical requirement for studies involving medical specialists and sensitive patient populations.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in India
212,800 panellists
- Primary & General96,566
- Acute, Peri-operative & Critical Care16,762
- Women's & Reproductive Health15,002
- Diagnostic & Laboratory14,274
- Internal Medicine Subspecialties13,396
- Nervous System & Mental Health11,284
Nurses and allied health panel, in India
169,480 panellists
- Registered Nurses49,317
- Advanced Practice Nurses3,070
- Licensed / Practical / Enrolled Nurses11,652
- Nursing Support (Aides / HCAs)4,392
- Midwives8,080
- Pharmacists & Pharmacy Techs13,668
Patient panel, in India
1,354,449 patient profiles
- Aesthetics & Cosmetic447,856
- Cardiovascular110,129
- Women's Health69,813
- Dermatology68,949
- Endocrinology & Metabolic65,890
- Preventive & Vaccine-preventable62,204
Across 731 conditions; a patient with more than one condition is counted once per condition.
Payers and providers panel, in India
2,610 panellists
- Provider: Access & Administrative Roles1,670
- Payer: Access & Coverage Roles940
Scorecard: 90.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 10/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 90.5 |
Core services
- Professional Panel Access: Provides direct access to healthcare professionals across 70+ specialties.
- Patient Insight Studies: Supports deep-dive research into patient journeys and treatment experiences.
- Provider Intelligence: Offers research solutions for payers and providers to understand care delivery.
- Specialist Nursing Access: Connects clients with nurses and allied health professionals for clinical feedback.
Strengths
- Proprietary Panel Ownership: Owns verified panels including 212,800 healthcare professionals and 1,354,449 patient profiles.
- Rigorous Data Verification: Employs identity fingerprinting and rolling validation of medical licenses to protect respondent authenticity.
- Regulatory Compliance: Operates under ISO 20252 and HIPAA standards, protecting safe handling of health data.
Innovation and technology
- Advanced Fraud Detection: Uses device fingerprinting and straight-lining detection to filter out non-human or low-quality responses.
- Digital Survey Platform: Hosts all projects on a proprietary platform designed for high-incidence healthcare surveys.
Impact on businesses
- Strategic Decision Support: Delivers insights that directly inform pharmaceutical launch and hospital market entry strategies.
- Risk Mitigation: Provides reliable data that helps brands avoid costly missteps in therapeutic positioning.
Why it may fit your brief
The agency is a strong match when the quality of respondent data is the primary driver of project success. When a study requires broad, non-medical consumer reach, other generalist firms may offer more cost-effective solutions.
IQVIA: best for large-scale real-world evidence and commercial analytics

Strongest fitIdeal for global pharma companies requiring large-scale data analytics and clinical research infrastructure.
IQVIA is a large-scale provider of data, technology, and analytics to the healthcare sector. Its operations in India are focused on supporting pharmaceutical and medtech companies through the entire lifecycle of their assets, from clinical trials to commercial execution.
The company provides a wide range of consultancy and analytical solutions, using its proprietary data assets to help clients predict market shifts and optimize their commercial performance. It is particularly known for its ability to integrate large datasets with clinical expertise.
Scorecard: 89.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 89.0 |
Core services
- Clinical Development: Offers full-service clinical trial solutions and site identification.
- Commercial Strategy: Provides analytics and consulting for market performance optimization.
- Real-World Evidence: Generates data-led insights to support product value and market access.
- Information Partner Services: Consults for pharmacies and wholesalers on tactical challenges.
Strengths
- Proprietary Data Network: Maintains a vast database of non-identified patient records and pharma sales data.
- Predictive Analytics: Uses AI-driven models to predict market trends and clinical outcomes.
- Functional Service Provider: Deploys flexible, co-created outsourcing solutions for clinical trial management.
Innovation and technology
- Agentic AI Platform: Deploys AI agents for field force optimization and global market intelligence.
- Connected Intelligence: Integrates people, processes, and technologies to improve clinical trial decision-making.
Impact on businesses
- Asset Maximization: Helps clients accelerate innovation and improve patient outcomes.
- Commercial Execution: Delivers actionable intelligence to increase market share and operational efficiency.
Why it may fit your brief
IQVIA is the primary choice for deep data-driven insights at scale. Smaller, more agile research projects may find its complex, high-level infrastructure less suitable than a specialized boutique firm.
Kantar: best for global brand equity and consumer health studies

Strongest fitIdeal for consumer-facing healthcare brands and pharmaceutical firms focusing on brand equity and patient-consumer behavior.
Kantar is a large research company that uses proprietary data and methodologies to help brands grow. Its healthcare practice in India combines global analytical frameworks with a strong local understanding of consumer and patient behavior.
The company is heavily invested in technology to protect data quality and offers a range of agile research products through its online platforms. Its work spans from brand equity measurement to product development research for healthcare innovators.
Scorecard: 81.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.5 |
Core services
- Survey Solutions: Provides agile research via global omnibus and custom surveys.
- Brand Equity Research: Measures brand health and valuation across diverse categories.
- Digital Audience Activation: Validates and targets audiences for digital media strategies.
- Creative Testing: Optimizes advertising effectiveness through consumer feedback.
Strengths
- Global Panel Network: Accesses millions of panelists across 100 markets programmatically.
- AI-Driven Quality: Uses Qubed AI technology to detect and stop fraudulent survey activity.
- Agile Products: Offers templated surveys for fast insights, often within two days.
Innovation and technology
- Qubed AI Tech: Employs five deep neural networks to protect respondent honesty and data integrity.
- Connected Data: Integrates survey data with first and third-party sources for a holistic view.
Impact on businesses
- Brand Growth: Guides businesses in building strong, sustainable market positions.
- ROI Optimization: Delivers insights that increase the profitability of creative and media investments.
Why it may fit your brief
Kantar is excellent for large-scale consumer research and brand measurement. It may be less focused on deep clinical or institutional B2B healthcare research compared to more specialized firms.
Ipsos: best for public health policy and system perception research

Strongest fitBest suited for large pharma and public health organizations requiring deep insights into market perceptions and system-level trends.
Ipsos maintains a strong presence in India with dedicated teams focused on the healthcare sector. The company provides a range of solutions that cover everything from brand health tracking for pharma to large-scale public health perception studies.
It emphasizes the need for deep understanding of the human element in research, using a mix of traditional polling, social media data, and qualitative inquiry to help clients make informed decisions in rapidly changing markets.
Scorecard: 81.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 81.5 |
Core services
- Healthcare Research: Tracks perceptions of healthcare systems and public health problems.
- Brand Health Tracking: Measures brand performance and market positioning.
- Qualitative Research: Conducts deep-dive studies via online communities and panels.
- Market Strategy: Provides analytical intelligence to support commercial decisions.
Strengths
- Deep Clinical Expertise: Maintains specialized healthcare teams focused on pharma and health policy.
- Global Trends Insight: Produces regular, high-level reports on global health and societal issues.
- Integrated Solutions: Combines data from polls, social media, and qualitative sources.
Innovation and technology
- Augmented Ipsos: Uses AI to enhance research delivery and provide faster, smarter insights.
- Online Communities: Engages patients and doctors in long-term, digital research environments.
Impact on businesses
- Smarter Decisions: Helps clients work through complex markets with evidence-based information.
- True Understanding: Provides a deep grasp of how society and patients view healthcare systems.
Why it may fit your brief
Ipsos is a strong partner for complex, high-level research. For small, quick-turnaround tactical projects, its large-scale structure might be less flexible than a boutique agency.
InsightRx: best for hospital-level referral network and catchment analysis

Strongest fitBest for hospital and diagnostic chains needing to understand local catchment dynamics and referral patterns.
InsightRx is a research and consulting firm that operates with a focus on granular, ground-level intelligence in India. It specializes in mapping patient flow, referral leakage, and institutional behavior in the hospital and diagnostic sectors.
The firm is known for its evidence-based approach, preferring primary research over secondary proxies. It operates across major urban agglomerations, providing intelligence that is tailored to the specific micro-market dynamics of cities like Pune and Delhi NCR.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | insightrx.in (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Hospital Intelligence: Maps referral networks and patient catchment areas.
- Pharma Research: Analyzes prescription behavior and therapy adoption trends.
- Medical Device Research: Evaluates clinician preference and technology adoption readiness.
- Public Health Research: Evaluates government scheme use and public health programs.
Strengths
- Primary Data Focus: Builds analytics on primary research rather than incomplete secondary proxies.
- Micro-Market Expertise: Understands that cities are sets of distinct healthcare markets, not monoliths.
- Referral Mapping: Specializes in identifying referral concentration and leakage risks.
Innovation and technology
- Primary-Grounded Analytics: Transforms survey data into strategic intelligence on patient flow and demand.
- Geographic Demand Mapping: Uses PIN-code level data to visualize healthcare demand and gaps.
Impact on businesses
- Expansion Planning: Guides healthcare organizations on where to launch and how to expand.
- Strategic Positioning: Provides brand perception benchmarking grounded in actual physician feedback.
Why it may fit your brief
It is highly specialized in the provider space. For global pharma firms needing large-scale, multi-country clinical data, a larger, multinational firm might be a more natural fit.
Unimrkt Healthcare: best for hybrid-methodology primary research and data collection

Strongest fitSuitable for companies requiring research across the entire care continuum, from pharma R&D to digital health payer solutions.
Unimrkt Healthcare is a specialized research provider that focuses on the pharma, medical technology, and digital health sectors. It uses a mix of traditional and modern research techniques to gather real-world evidence and physician feedback.
The company maintains a strong commitment to quality and ethical standards, holding multiple ISO and HIPAA certifications. Its work is designed to support the entire commercialization process, from early-stage concept testing to the delivery of medical solutions.
Scorecard: 76.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | unimrkthealth.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.5 |
Core services
- Primary Research: Conducts surveys and interviews across the healthcare network.
- Medical Device Research: Assesses market potential for capital and consumable medical equipment.
- Digital Health Studies: Provides research on digital interventions and payer solutions.
- Strategic Solutions: Offers advisory services for hospitals, providers, and insurers.
Strengths
- Rigorous Certifications: Holds ISO 20252, ISO 27001, and HIPAA certifications.
- Industry Expertise: Staffed by professionals with advanced healthcare education backgrounds.
- Hybrid Methods: Combines CATI and online panels for comprehensive data gathering.
Innovation and technology
- Digital Transformation Research: Focuses on the impact of digital technology on payer and provider value chains.
- Collaborative Approaches: Works directly with hospitals and health systems to derive actionable insights.
Impact on businesses
- Value-Based Care Support: Helps providers and insurers work through the shift to value-based care.
- Operational Efficiency: Provides planning decisions that drive better patient-centric outcomes.
Why it may fit your brief
The firm’s focus on ethical compliance and hybrid methods makes it a strong choice for sensitive primary research. For projects needing purely macro-level market sizing without primary data, other firms might be more cost-efficient.
BioNixus: best for account-level brand vs competitor intelligence

Strongest fitDesigned for marketing and commercial leads needing specific, account-level performance data to guide product launches.
BioNixus focuses on delivering primary research that provides granular visibility into market performance. Its approach in India is designed to supplement syndicated data feeds by focusing on specific accounts and sub-regions that are often missed by larger, national-average reports.
The company is organized into healthcare-specific and non-healthcare silos, making sure that its life sciences work remains aligned with regulatory and ethical standards. It is geared toward marketing and commercial teams that need actionable, high-frequency intelligence.
Scorecard: 74.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | bionixus.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.0 |
Core services
- Primary Research: Designs studies for physician and payer insights.
- Strategic Consulting: Supports launch readiness and market access strategies.
- Competitive Intelligence: Provides SKU-level brand versus competitor performance data.
- KOL Mapping: Identifies and engages key opinion leaders for pharma marketing.
Strengths
- Granular Data Depth: Focuses on sub-account and SKU-level breakdowns not found in syndicated feeds.
- Rapid Turnaround: Delivers research proposals within 48 hours of brief receipt.
- Healthcare Depth: Maintains a specialized silo for regulated life sciences and pharma work.
Innovation and technology
- Decision Packs: Outputs findings as tailored decision packs rather than raw dashboard exports.
- Cognitive Load Design: Tailors conjoint and MaxDiff experiments to the time constraints of clinicians.
Impact on businesses
- Launch Optimization: Helps commercial teams design campaigns based on local account dynamics.
- Strategic Clarity: Converts primary evidence into clear decisions on portfolio priority.
Why it may fit your brief
It is highly effective for tactical commercial planning. For companies needing broad, national-level population health data or generic brand trackers, other firms may be more appropriate.
InVeritas Research: best for difficult-to-reach physician subspecialty recruitment

Strongest fitSuitable for organizations needing specific physician subspecialty insights and a mix of traditional and digital qualitative methods.
InVeritas Research is a research company with operations in India that manages both quantitative and qualitative projects. It specializes in recruiting hard-to-reach audiences, including specific physician subspecialties and senior business decision-makers.
The company emphasizes high-quality data collection and uses a multi-disciplinary team to manage projects from design to delivery. Its work in the healthcare sector is primarily focused on medical devices, diagnostics, and brand performance studies.
Scorecard: 72.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | inveritasresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 72.5 |
Core services
- Qualitative Research: Conducts focus groups, in-depth interviews, and ethnography.
- Quantitative Data Collection: Executes surveys via CATI, CAPI, and online platforms.
- Brand Market Research: Supports brand leadership through competitive insight and market data.
- Consulting and Analytics: Provides strategic analysis based on primary research findings.
Strengths
- Specialized Recruitment: Maintains experience in recruiting difficult respondents like transplant surgeons.
- Quality Control SOPs: Follows rigorous internal check processes by dedicated quality teams.
- Global Capabilities: Executes fieldwork across multiple continents including Asia and Africa.
Innovation and technology
- Hybrid Methodologies: Combines qualitative and quantitative techniques to uncover hidden market truths.
- Online Bulletin Boards: Uses digital platforms to engage with respondents for qualitative insights.
Impact on businesses
- Commercial Soundness: Enables stakeholders to make bold, data-driven decisions.
- Market Leadership: Helps brands outperform in their local target markets.
Why it may fit your brief
It is an effective choice for complex recruitment tasks. For projects requiring purely syndicated data or large-scale clinical trial monitoring, other providers may be better aligned.
FieldNet Global: best for large-scale multi-city brand health tracking

Strongest fitWell-suited for consumer-facing healthcare brands and large-scale retail audits where field execution is essential.
FieldNet Global is a research agency that delivers integrated approaches to data collection across India and other global regions. The firm is led by industry veterans and focuses on translating research into actionable growth strategies.
Its healthcare work is part of a broader portfolio that includes retail and FMCG research, with a strong emphasis on large-scale measurement projects and on-ground activations. It is well-regarded for its operational capacity in managing multi-city studies.
Scorecard: 72.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | fieldnetglobal.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 72.5 |
Core services
- Market Research: Executes surveys, focus groups, and in-depth interviews.
- Audits and Polls: Handles large-scale measurement including retail census and mystery shopping.
- Data Analysis: Provides advanced statistical modeling and content analysis.
- On-ground Activations: Delivers retail execution to translate strategy into action.
Strengths
- Geographic Reach: Operates across 50+ countries with strong local presence in India.
- Management Experience: Core team brings collective experience from major global research firms.
- Quality Controls: Implements real-time monitoring and independent auditing for data accuracy.
Innovation and technology
- Integrated Decision Network: Connects research and retail data into a single decision-making framework.
- Real-time Collection: Uses advanced tools to make sure data capture is immediate and accurate.
Impact on businesses
- Growth Planning: Helps brands achieve measurable success through data-driven insights.
- Market Intelligence: Transforms data into actionable recommendations for business growth.
Why it may fit your brief
The firm excels in large-scale fieldwork. It may be less suitable for highly niche clinical trials or specialized medical device adoption studies that require deep physician-only focus.
DelveInsight: best for syndicated pharmaceutical market intelligence reports
Strongest fitIdeal for pharma companies seeking off-the-shelf market intelligence and strategic forecasting for specific therapy areas.
DelveInsight operates as a research and consulting hub that provides deep-dive reports and strategic analysis. It serves a global client base, with a focus on therapy areas and geographic market intelligence.
Its work is primarily directed at helping life sciences companies understand market potential, competitive moves, and regulatory hurdles. It is a source for syndicated research that informs long-term strategic planning for pharmaceutical and medical device manufacturers.
Scorecard: 66.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | Search results and industry sources, Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | Search results and industry sources, Oct 2026 |
| Target Audience Reach | 15 | 6/10 | Search results and industry sources, Oct 2026 |
| Research Quality | 10 | 7/10 | Search results and industry sources, Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 6/10 | Search results and industry sources, Oct 2026 |
| Analytical Capability | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Client Service and Speed | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | Search results and industry sources, Oct 2026 |
| Weighted score | 100 | 66.5 |
Core services
- Market Intelligence: Produces detailed reports on therapeutic areas and market segments.
- Forecasting Analysis: Provides data-driven projections for market growth and drug uptake.
- Competitive Assessments: Maps the competitive environment for pharma and biotech products.
- Strategic Consulting: Offers advisory services for market entry and product positioning.
Strengths
- Sector Specialization: Focuses exclusively on healthcare, pharma, and medical devices.
- Deep Therapy Knowledge: Maintains expertise across a range of complex medical therapy areas.
- Strategic Focus: Delivers insights designed to support high-level corporate decision-making.
Innovation and technology
- Data Forecasting: Uses proprietary models to predict future market performance.
- Report Portals: Provides access to a library of intelligence on emerging trends.
Impact on businesses
- Informed Planning: Supports clients in making educated decisions on R&D and commercialization.
- Market Visibility: Gives companies a clear view of the competitive pressures in their therapy areas.
Why it may fit your brief
It is an efficient source for secondary intelligence. For projects requiring unique, primary data collection from specific Indian patient or physician groups, a firm with direct fieldwork capabilities would be better.
How HCP and patient verification actually works in India
Make sure every research participant is verified through identity fingerprinting, license checks, and multi-factor authentication to maintain data integrity.
Verification of Professionals
For healthcare professionals, verification should involve cross-referencing registration numbers against official medical council databases. Agencies must demonstrate that they update these records periodically, as physician status can change. Ask for proof of how they filter out inactive or retired clinicians. Without this, your sample may include individuals who are no longer practicing or who lack the current clinical experience to provide valid feedback on treatment pathways or device usage.
Identity and Fraud Detection
Quality providers use device and identity fingerprinting to make sure that one person is not participating in multiple surveys or using bots. You should ask the provider for their rate of duplicate removal and how they handle VPN or proxy detection. If an agency cannot explain how they block fraudulent completes, the reliability of their quantitative data will be compromised by automated responses that mimic human input.
Patient Panel Validation
Patient verification is more complex due to privacy concerns. Providers should use a double opt-in process and verify health conditions through self-reported medical history that is checked against previous survey responses. Ask the agency how they confirm that the patients in their panel actually have the conditions they claim to have. A firm that lacks a solid validation process for its patient panels will likely produce data based on inaccurate or misidentified cohorts.
Adverse Event Protocols
In healthcare research, verification also extends to the safety of the process. An agency must have a clear procedure for reporting adverse events or product complaints mentioned by respondents. Ask to see their standard operating procedure for handling such data in compliance with BHBIA or similar local guidelines. An agency that does not have a formal protocol for this is failing to meet basic ethical and legal requirements in the life sciences sector.
How to choose the right provider in India
Choose a research agency by balancing deep clinical expertise, rigorous data security, and the ability to access your specific target audience in India.
- Assess panel ownership: Ask if the agency owns its panels or rents them from open exchanges. Proprietary panels offer better quality control and deeper respondent profiling.
- Check regulatory compliance: Confirm that the firm adheres to HIPAA, GDPR, and local Indian data laws. Healthcare data requires higher security standards than generic consumer data.
- Evaluate local expertise: Make sure the agency understands the regional nuances of the Indian market. A firm with deep local hospital knowledge is better than one using only national proxies.
- Review analytical depth: Demand examples of how they turn raw data into strategic insights. Choose a partner that offers actionable recommendations, not just basic reporting.
- Validate fieldwork quality: Ask how they detect fraud and protect respondent honesty. A reliable partner will have clear, transparent protocols for data cleaning and validation.
Questions to ask before you commission
- Can you provide proof of your data verification process for medical specialists and patients?
- How do you handle adverse event reporting during the course of a research project?
- What specific measures do you take to identify and remove fraudulent survey completes?
- How do you make sure your sample is representative of the diverse healthcare micro-markets in India?
- Can you explain your experience in mapping referral networks for hospital providers?
- What proprietary data or panels do you use to access niche patient populations?
Common pitfalls to avoid
- Relying on syndicated data: Using only national-level syndicated reports often misses critical regional nuances in hospital referral patterns and patient behavior.
- Ignoring panel sourcing: Renting respondents from open-internet pools often results in low-quality or non-representative data that does not reflect actual clinical realities.
- Skipping adverse event plans: Failing to have a protocol for reporting product complaints can lead to significant ethical and regulatory risks during research.
- Overlooking micro-market diversity: Treating India as a single market leads to poor strategy; always protect the provider accounts for local differences in bed density and payer mix.
What a feasibility check should include
A formal feasibility check must assess the availability of your target audience, the expected incidence rate, and the time required for ethical validation.
Incidence rate reality
Ask the provider for a realistic assessment of the incidence rate for your target group. Over-optimistic estimates often lead to delays and budget overruns.
Ethical validation time
Protect the feasibility plan accounts for the time needed to verify medical credentials. This is essential for maintaining data quality in Indian healthcare studies.
Regional reach assessment
Check if the provider has enough respondents in the specific geographies you need. Large panels often lack depth in Tier-2 and Tier-3 cities.
Constraint disclosure
A good partner will proactively disclose what is not possible within your budget. Avoid providers that promise access to impossible niche groups without caveats.
Conclusion
Selecting the right research partner for your healthcare projects in India requires a careful assessment of the provider’s ability to combine clinical depth with rigorous operational standards. For studies requiring high-fidelity access to verified medical specialists and patient populations, Global Vox Populi stands out for its proprietary panel ownership and strict data validation protocols. If your brief centers on large-scale commercial analytics and real-world evidence, firms like IQVIA provide the necessary infrastructure and data breadth.
For those focused on hospital referral mapping and institutional intelligence in India, InsightRx offers a specialized, ground-level perspective that is essential for regional strategy. Always use the scorecard criteria to evaluate providers against your specific research needs, and do not hesitate to request transparency regarding panel sourcing and data verification. Ultimately, the best choice is a provider that treats data quality as a non-negotiable foundation for your strategic decisions.
Planning research in India? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
Which are the top healthcare market research companies in India?
The market includes several capable firms. Global Vox Populi is highly regarded for its proprietary panels and primary research. IQVIA is a major player for data-led commercial strategy. InsightRx specializes in hospital and provider intelligence, while firms like Ipsos and Kantar offer strong global methodologies for brand and public health research.
How to choose a healthcare research agency in India?
Choose by evaluating the firm's specific experience with your target audience and their commitment to data quality. Verify their ISO and HIPAA certifications, ask about their panel ownership to make sure they are not renting participants, and look for a partner that provides actionable strategic insights rather than just raw data.
What services do Indian healthcare market research firms provide?
Services typically include physician and patient surveys, hospital referral network mapping, brand health tracking, medtech adoption studies, and competitive environment assessments. Some firms also offer strategic consulting, market entry feasibility analysis, and public health program evaluation for government and private healthcare sectors.
Are there specialized pharma market research agencies in India?
Yes, several agencies specialize in pharma research. Firms like BioNixus and InsightRx focus specifically on life sciences, offering services such as KOL mapping, prescription behavior studies, and launch readiness assessments. These firms are structured to handle the specific regulatory and ethical requirements of pharmaceutical market research.
How does CDSCO regulation impact healthcare research in India?
CDSCO regulations govern clinical trials and the ethical standards for medical research in India. Any agency conducting primary healthcare research must be aligned with these ethical guidelines to protect patient safety and data integrity. Providers must demonstrate that their research design respects these standards, particularly when dealing with patient data.
Which companies provide HCP and patient insight studies in India?
Global Vox Populi provides deep-profiled panels for both HCPs and patients. InVeritas Research and InsightRx also offer significant capabilities in recruiting physicians and patients for qualitative and quantitative studies. These firms excel at capturing the nuanced behavioral data needed to map patient journeys and physician decision-making.
What is the importance of proprietary panels in healthcare research?
Proprietary panels are essential because they allow the agency to verify the credentials of medical professionals and the health conditions of patients. Renting from open markets often results in low-quality data. Owning the panel makes sure that participants are who they say they are and that their profiles are kept up to date.
Why is hospital referral mapping critical in India?
India's hospital market is highly fragmented and relies on complex referral networks. Mapping these networks allows healthcare organizations to understand where patients come from and why they choose one provider over another. Without this intelligence, firms often struggle to predict market share or identify high-potential feeder markets.